Document:

f8k0211ex10xix_adsinmotion.htm

Exhibit 10.19

 

MAGLA PRODUCTS, L.L.C.

 

AMENDED AND RESTATED 

NONQUALIFIED DEFERRED COMPENSATION PLAN

 

AGREEMENT, made this 21st day of December, 2007, by and between MAGLA PRODUCTS, L.L.C, a New Jersey limited liability company, located at 159 South Street, Morristown, New Jersey, 07960 (the "Company") and ALISON CARPINELLO, residing at 2419 Homestead Avenue, Spring Lake, New Jersey, 07762 (the "Executive"),

 

RECITALS

 

                                 WHEREAS:

(1) The Executive's services are of considerable value to the Company and the Company wishes to offer an incentive to the Executive to remain in its employ by providing additional deferred compensation benefits to the Executive in the future to supplement his/her regular compensation and bonuses; and

 

(2) Magla Products, Inc., a predecessor to the Company, established a nonqualified Deferred Compensation Plan for the Executive on January 22, 1998 (the "Plan"),

 

(3) The Company and the Executive desire to amend and restate the Deferred Compensation Plan in accordance with § 409A of the Internal Revenue Code, as amended.

 

 NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, it is agreed between the parties hereto as follows:

 

(1) Deferred compensation. The Company shall establish and maintain a deferred compensation account for the Plan ("Account" or "Deferred Compensation Account") in the name of the Executive. The Company shall credit to the Executive's Account the cash value of the life insurance policy set forth in paragraph 2 of this agreement together with any interest or earnings on the Account.

 

(2) Account index. The value of the Executive's Deferred Compensation Account at any time shall be the cash value of the life insurance policy on the life of the Executive as follows:

 

	
Insurance Company

	
Massachusetts Mutual Life Insurance Company

	
Type of policy

	
variable life select

	
Policy No

	
7917266

	
Initial face amount/death benefit

	
$450,000

	
Death benefit option/dividend election

	
death benefit level

	
Annual premium

	
$5,000

	
Executive's insurance age and rating

	
36 (as 01.22.98)/nontabacco

  

~1~

  

 

 The Executive agrees to assist the Company in making application for the above policy on the life of the Executive by submitting to any required physical examination and providing any information necessary for the completion of such application. The Company shall be owner and beneficiary of such policy and shall pay the premiums and other expenses, if any, thereon.

 

 The Company shall not be liable for, and it makes no warranty with respect to, the results of the Account. All right, title and interest in and to all amounts credited to the Account shall at all times be the sole property of the Company, and shall in no event be deemed to constitute a fund or collateral security for the payments under the Plan. All amounts credited to the Account shall for all purposes be a part of the general funds of the Company. To the extent that the Executive or his/her designee acquires a right to receive payments under the Plan, such right shall be not greater than the right of any unsecured general creditor of the Company. Neither the Executive nor his/her designee shall have any interest whatsoever in any amount credited to the Account, except as set forth herein.

 

                                (3) Retirement benefits. In the event the Executive retires from employment with the Company upon attaining the retirement age of 65 years, he/she shall be paid an amount equal to what would have been the cash value of the indexed life insurance policy as set forth in paragraph 2 of this agreement at that time, payable in equal monthly installments for a period of five (5) years, beginning the first day of the month, two (2) months after the date of retirement. If the Executive should die during the said five (5) year period, the Company shall continue to pay such monthly installments until the expiration of said five (5) year period to such individual or individuals as the Executive has designated in writing filed with the Company or, in the absence of such designation, to the estate of the Executive.

 

(4) Preretirement death benefits.   If the Executive dies while employed by the Company, other than by suicide within two (2) years of the date of this agreement, prior to attaining his/her retirement age of 65 years, the Company shall pay to such individual or individuals as the Executive shall have designated in writing filed with the Company, a benefit equal to that which would be available to the Company at the date of the Executive's death from the indexed life insurance policy referred to in paragraph 2 of this agreement at that time. Such payment shall be made in one lump sum or in equal monthly installments, as provided in the Executive's election filed with the Company. In the event that the Executive shall fail to designate a method of payment or any beneficiary, the benefit shall be paid in one lump sum to the person, or divided equally among all the persons, in the first of the following classes in which there shall be any survivors of the Executive;

                                                                (a) His/her spouse;

                                                                (b) His/her descendants, or

                                                                (c) His/her executors or administrators.

  

~2~

  

 

                                (5) Vesting and severance benefits. In the event the Executive's employment with the Company terminates for reasons other than Just Cause, death, disability (as provided in paragraph 6 of this agreement) or retirement, he/she shall be entitledto a severance benefit based on a percentage of what would have been the cash value of the indexed policy referred to in paragraph 2 of this agreement at that time, depending on the Executive's total full years of service with the Company, as follows:

 

	
Full years of service

	
vesting percentage

	
Less than 1 year

	
0%

	
1 year

	
10%

	
2 years

	
20%

	
3 years

	
30%

	
4 years

	
40%

	
5 years

	
50%

	
6 years

	
60%

	
7 years

	
70%

	
8 years

	
80%

	
9 years

	
90%

	
10 or more years

	
100%

 

 Any severance benefit shall be paid in the same manner as set forth in paragraph 3 above, except that the date of the Executive's termination shall be substituted for the date of retirement. Such benefit shall be paid by the Company not later than the first day of the month two (2) months after severance for a period of five (5) years. If the Executive should die during said five (5) year payment period, the Company shall continue to pay such payments, until the expiration of said five (5) year period to the Executive's beneficiary or beneficiaries in accordance with paragraph 4 of this agreement.

 

 Notwithstanding anything contained in this agreement to the contrary, if the Executive's employment with the Company terminates due to the disability of the Executive (paragraph 6), or for other than Just Cause, or there is a Change of Control event of the Company as described in Reg. 1.409A-3(i)(5) ("Change of Control"), the Executive shall be 100% vested in his/her Deferred Compensation Account. Further, in the event of the foregoing, the Executive shall have the option to purchase any life insurance policy(ies) on his/her life owned by the Company within sixty (60) days after the Executive's employment terminates due to disability, for other than Just Cause or due to a Change of Control of the Company and the policy(ies) shall be delivered to the Executive who shall be responsible for any income tax consequences and premiums in connection therewith.

 

 The term "Just Cause" means (a) the Executive's fraud, embezzlement, misappropriation, dishonesty, wilful misconduct, gross negligence, or serious misconduct which reflects unfavorably upon the Company; or (b) any willful failure to perform his/her duties under this agreement if such willful failure is not cured within thirty (30) day's after written notice thereof specifying such willful failure from the Company to the Executive.

  

~3~

  

 

 If the Executive's employment with the Company is terminated for Just Cause, this agreement shall terminate and the Deferred Compensation Plan shall terminate and the Executive shall have no right in or to the Deferred Compensation Account or the life insurance policy maintained as set forth in paragraph 2 of this agreement.

 

                               (6)      Disability benefits. If the Executive becomes totally and permanently disabled prior to his/her retirement or severance of employment with the Company, and his/her disability continues for period of six (6) months; then regardless of the Executive's length of service with the Company, the Company shall pay a disability benefit to the Executive in the same manner as set forth in paragraph 3 above except that the date of the Executive's disability shall be substituted for the date of retirement. Such benefit shall be paid by the Company beginning not later than the first day of the month six (6) months after disability.   If the Employee should die during an installment payment period, the Company shall continue to pay such monthly installments until the expiration of the installment period to the Executive's beneficiary or beneficiaries in accordance with paragraph 4 above.

 

 For purposes of this paragraph, the Executive shall be considered disabled if he/she is unable to engage in any substantial gainful activity by reason of any medically determinate physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months.

 

(7)      Restrictive covenant. During the period that the Executive is receiving benefits pursuant to this agreement the Executive shall not, directly or indirectly, enter into, or in any manner take part in any business, or other endeavor as an employee, agent, independent contractor, owner, or otherwise which is in competition with the Company's business without the Company's prior written consent. If the Executive breaches this provision, this agreement shall immediately be terminated. In this event, the Executive shall immediately forfeit all rights to the benefits the Executive is receiving or is entitled to receive from the Company under this agreement. This restrictive covenant shall not apply if the Executive's employment with the Company is terminated for other than Just Cause or due to a Change of Control of the Company.

 

(8)      Determination   of   benefits,   claims   procedure   and   administration.   The determination of benefits, claims procedures, and plan administration shall be as follows:

 

                                           (a)    Claim.

 

A person who believes that he/she is being denied a benefit to which he/she is entitled under this agreement (hereinafter called a "Claimant") may file a written request for such benefit with the Company, setting forth his/[her claim. The request must be addressed to the President or Managing Member of the Company at its then principal place of business.

  

~4~

  

                                           (b)        Claim Decision.

 

Upon receipt of a claim, the Company shall advise the Claimant that a reply will be forthcoming within sixty (60) days [which may be extended for an additional thirty (30) days for reasonable cause].

 

If the claim is denied in whole or in part, the Company shall adopt a written opinion, using language calculated to be understood by the Claimant, setting forth:

               

               (i) The specific reason or reasons for such denial;

 

               (ii) The specific reference to pertinent provisions of this agreement upon which such denial is based;

 

(iii) A description of any additional material or information necessary for the Claimant to perfect his/[her claim and an explanation why such information is necessary;

 

(iv) Appropriate information as to the steps to be taken if the Claimant wishes to submit the claim for review; and

 

               (v) The time limits for requesting such a review.

 

                                           (c)        Request for Review.

 

Within sixty (60) days after the receipt by the Claimant of the written opinion described above, the Claimant may request in writing that the President or Managing Member of the Company review the determination of the Company. Such request must be addressed to the President or Managing Member of the Company, at its then principal place of business. The Claimant or his/her duly authorized representative may, but need not, review the pertinent documents and submit issues and comments in writing for consideration by the Company. If the Claimant does not request a review of the Company's determination by the President or Managing Member of the Company within such sixty (60) day period, he/she shall be barred from challenging the Company's determination.

 

                                           (d)        Review of Decision

 

Within thirty (30) days after the President's or Managing Member's receipt of a request for review, he/she will review the Company's determination. After considering all materials presented by the Claimant, the President or Managing Member will render a written opinion, written in a manner calculated to be understood by the Claimant, setting froth the specific reasons for the decision and containing specific references to the pertinent provisions of this agreement on which the decision is based. If special circumstances require that the thirty (30) day time period be extended, the President or Managing Member will so notify the Claimant and will render the decision as soon as possible, but no later than sixty (60) days after receipt of the request for review.

 

(9) Notices. Any notices or other communications provided for in this agreement or given pursuant to this agreement shall be in writing and shall be deemed given for all purposes when either served personally or three (3) business days after being mailed by certified or registered mail, return receipt requested, postage prepaid, or upon receipt if sent be nationally recognized overnight courier or facsimile and addressed to the respective party at its last known address.

  

~5~

  

 

    (10) Inurement of benefits. This agreement shall be binding upon and inure to the benefit of the Executive and his/her heirs, personal and legal representatives and the Company and its successors and assigns, including, without limitation, entities or persons involved in or effecting a Change of Control of the Company.

 

    (11) Venue.   To the extent any litigation should be brought, or arise out of, in connection with or by reason of this agreement, the parties consent to the other party filing an action in the state or federal courts located in the State of New Jersey and further agree that such courts shall be exclusive courts of jurisdiction and venue for any litigation which any party may file and agree that service of process and service of any other papers may be made on the parties by mailing a copy thereof to their respective addresses by first-class mail, postage prepaid or by facsimile.

 

    (12) Miscellaneous.   This agreement constitutes the entire understanding and agreement between the parties hereto, supersedes and replaces all prior written or oral agreements between the parties and may not be amended, modified or supplemented in any respect except by a subsequent written agreement entered into by both parties hereto and may not be otherwise terminated except as set forth herein. This agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. A fully executed copy shall be deemed an original for all purposes. The RECITALS set forth above are incorporated into this agreement and made apart thereof. This agreement shall be governed by and construed in accordance with the internal laws of the State of New Jersey without regard to choice of law principles. The waiver by any party of the breach of any provision of this agreement shall not operate or be construed as a waiver of any other or subsequent breach. The invalidity of any portion of this agreement shall not affect the validity of the remainder of this agreement.   No amendment, supplement or termination of this agreement shall affect or impair any rights or obligations which shall have matured prior thereto.

 

     IN WITNESS WHEREOF, the parties have executed this amended and restated Plan the day and year first above written.

 

	 	MAGLA PRODUCTS, L.L.C	 
	 	Company	 
	 	 	 	 

	 	 	 	 	 
	                                    	
/s/ Alison Carpinello

	 By:  	
/s/ Jordan Glatt

	 
	 	
Alison Carpinello - Executive

	 	
Jordan Glatt, President

	 
	 	
 

	 	
 

	 

 

 

  

~6~

  

 

 

 ~7~Exhibit 4.1

Certificate No. A-101

CLASS A REDEEMABLE WARRANT 

TO PURCHASE _________ SHARES OF COMMON STOCK 

OF 

DAVI LUXURY BRAND GROUP, INC.

(formerly Dafoe Corp.)

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “1933 ACT”) OR UNDER ANY STATE SECURITIES OR “BLUE SKY” LAWS (“BLUE SKY LAWS”). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT OR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT OR ANY INTEREST THEREIN MAY BE MADE EXCEPT (a) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT AND ANY APPLICABLE BLUE SKY LAWS OR (b) IF THE CORPORATION HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE REASONABLY SATISFACTORY TO THE CORPORATION, TO THE EFFECT THAT NO REGISTRATION IS REQUIRED BECAUSE OF THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT AND APPLICABLE BLUE SKY LAWS. 

THIS CERTIFIES THAT, for good and valuable consideration _________________, or the Holder’s registered assigns, is entitled to subscribe for and purchase from Davi Luxury Brand Group, Inc., a Nevada corporation formerly known as Dafoe Corp. (the “Corporation”), at any time after the date of this Class A Redeemable Warrant (the “Warrant”), to and including December 31, 2012, _____________ (________) fully paid and nonassessable shares of the Common Stock of the Corporation at the price of $.60 per share (the “Warrant Exercise Price”), subject to the antidilution provisions of this Warrant. 

The shares which may be acquired upon exercise of this Warrant are referred to herein as the “Warrant Shares.” As used herein, the term “Holder” means the Holder, any party who acquires all or a part of this Warrant as a registered transferee of the Holder, or any record holder or holders of the Warrant Shares issued upon exercise, whether in whole or in part, of the Warrant. The term “Common Stock” means the common stock, $0.001 par value per share, of the Corporation. This Warrant issued in connection with a private placement by the Corporation pursuant to a Securities Purchase Agreement dated January ___, 2011. 

This Warrant is subject to the following provisions, terms and conditions: 

1.

EXERCISE; TRANSFERABILITY. 

(a)

The rights represented by this Warrant may be exercised by the Holder hereof, in whole or in part (but not as to a fractional share of Common Stock), by written notice of exercise (in the form attached hereto) delivered to the Corporation at the principal office of the Corporation prior to the expiration of this Warrant and accompanied or preceded by the 

1

surrender of this Warrant along with a check in payment of the Warrant Exercise Price for such Warrant Shares. 

(b)

Except as provided in Section 7 hereof, this Warrant may not be sold, transferred, assigned, hypothecated or divided into two or more Warrants of smaller denominations, nor may any Warrant Shares issued pursuant to exercise of this Warrant be transferred. 

2.

EXCHANGE AND REPLACEMENT. Subject to Sections 1 and 7 hereof, this Warrant is exchangeable upon the surrender hereof by the Holder to the Corporation at its office for new Warrants of like tenor and date representing in the aggregate the right to purchase the number of Warrant Shares purchasable hereunder, each of such new Warrants to represent the right to purchase such number of Warrant Shares (not to exceed the aggregate total number purchasable hereunder) as shall be designated by the Holder at the time of such surrender. Upon receipt by the Corporation of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and, in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of this Warrant, if mutilated, the Corporation will make and deliver a new Warrant of like tenor, in lieu of this Warrant. This Warrant shall be promptly canceled by the Corporation upon the surrender hereof in connection with any exchange or replacement. The Corporation shall pay all expenses, taxes (other than stock transfer taxes), and other charges payable in connection with the preparation, execution, and delivery of Warrants pursuant to this Section 2. 

3.

ISSUANCE OF THE WARRANT SHARES. 

(a)

The Corporation agrees that the Warrant Shares shall be and are deemed to be issued to the Holder as of the close of business on the date on which this Warrant shall have been surrendered and the payment made for such Warrant Shares as aforesaid. Subject to the provisions of paragraph (b) of this Section 3, certificates for the Warrant Shares so purchased shall be delivered to the Holder within a reasonable time after the rights represented by this Warrant shall have been so exercised, and, unless this Warrant has expired, a new Warrant representing the right to purchase the number of Warrant Shares, if any, with respect to which this Warrant shall not then have been exercised shall also be delivered to the Holder. 

(b)

Notwithstanding the foregoing, however, the Corporation shall not be required to deliver any certificate for Warrant Shares upon exercise of this Warrant except in accordance with exemptions from the applicable securities registration requirements or registrations under applicable securities laws. Nothing herein shall obligate the Corporation to effect registrations under federal or state securities laws. If registrations are not in effect and if exemptions are not available when the Holder seeks to exercise the Warrant, the Warrant exercise period will be extended, if need be, to prevent the Warrant from expiring, until such time as either registrations become effective or exemptions are available, and the Warrant shall then remain exercisable for a period of at least 30 calendar days from the date the Corporation delivers to the Holder written notice of the availability of such registrations or exemptions. The Holder agrees to execute such documents and make such representations, warranties, and agreements as may be required solely to comply with the exemptions relied upon by the Corporation, or the registrations made, for the issuance of the Warrant Shares. 

2

4.

COVENANTS OF THE CORPORATION. The Corporation covenants and agrees that all Warrant Shares will, upon issuance, be duly authorized and issued, fully paid, nonassessable and free from all taxes, liens and charges with respect to the issue thereof. The Corporation further covenants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Corporation will at all times have authorized and reserved for the purpose of issue or transfer upon exercise of the subscription rights evidenced by this Warrant a sufficient number of shares of Common Stock to provide for the exercise of the rights represented by this Warrant.   The Corporation will not take any action which would result in any adjustment of the Warrant Exercise Price if the total number of shares of Common Stock issuable after such action upon exercise of all outstanding warrants, together with all shares of Common Stock then outstanding and all shares of Common Stock then issuable upon exercise of all options and upon the conversion of all convertible securities then outstanding, would exceed the total number of shares of Common Stock then authorized by the Corporation’s Articles of Incorporation, as amended.

5.

ANTI-DILUTION ADJUSTMENTS. The provisions of this Warrant are subject to adjustment as provided in this Section 5. 

(a)

The Warrant Exercise Price shall be adjusted from time to time such that in case the Corporation shall hereafter: 

(i)

pay any dividends on any class of stock of the Corporation payable in Common Stock or securities convertible into Common Stock; 

(ii)

subdivide its then outstanding shares of Common Stock into a greater number of shares; or 

(iii)

combine outstanding shares of Common Stock, by reclassification or otherwise; 

then, in any such event, the Warrant Exercise Price in effect immediately prior to such event shall (until adjusted again pursuant hereto) be adjusted immediately after such event to a price (calculated to the nearest full cent) determined by dividing (A) the number of shares of Common Stock outstanding immediately prior to such event, multiplied by the then existing Warrant Exercise Price, by (B) the total number of shares of Common Stock outstanding immediately after such event (including in each case the maximum number of shares of Common Stock issuable in respect of any securities convertible into Common Stock), and the resulting quotient shall be the adjusted Warrant Exercise Price per share. An adjustment made pursuant to this Subsection shall become effective immediately after the record date in the case of a dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification. If, as a result of an adjustment made pursuant to this Subsection, the Holder of any Warrant thereafter surrendered for exercise shall become entitled to receive shares of two or more classes of capital stock or shares of Common Stock and other capital stock of the Corporation, the Board of Directors (whose determination shall be conclusive) shall determine the allocation of the adjusted Warrant Exercise Price between or among shares of such classes of capital stock or shares of Common Stock and other capital stock. All calculations under this Subsection shall be made to the nearest cent or to the nearest 1/100 of 

3

a share, as the case may be. In the event that at any time as a result of an adjustment made pursuant to this Subsection, the holder of any Warrant thereafter surrendered for exercise shall become entitled to receive any shares of the Corporation other than shares of Common Stock, thereafter the Warrant Exercise Price of such other shares so receivable upon exercise of any Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to Common Stock contained in this Section. 

(b)

Upon each adjustment of the Warrant Exercise Price pursuant to Section 5(a) above, the Holder of each Warrant shall thereafter (until another such adjustment) be entitled to purchase at the adjusted Warrant Exercise Price the number of shares, calculated to the nearest full share, obtained by multiplying the number of shares specified in such Warrant (as adjusted as a result of all adjustments in the Warrant Exercise Price in effect prior to such adjustment) by the Warrant Exercise Price in effect prior to such adjustment and dividing the product so obtained by the adjusted Warrant Exercise Price. 

(c)

In case of any consolidation or merger to which the Corporation is a party other than a merger or consolidation in which the Corporation is the continuing corporation, or in case of any sale or conveyance to another corporation of the property of the Corporation as an entirety or substantially as an entirety, or in the case of any statutory exchange of securities with another corporation (including any exchange effected in connection with a merger of a third corporation into the Corporation), there shall be no adjustment under Subsection (a) of this Section 5 but the Holder of this Warrant shall have the right thereafter to receive upon exercise of this Warrant the kind and amount of shares of stock and other securities and property which he would have owned or have been entitled to receive immediately after such consolidation, merger, statutory exchange, sale, or conveyance had such Warrant been exercised immediately prior to the effective date of such consolidation, merger, statutory exchange, sale, or conveyance and, in any such case, if necessary, appropriate adjustment shall be made in the application of the provisions set forth in this Section with respect to the rights and interests thereafter of any Holders of the Warrant, to the end that the provisions set forth in this Section shall thereafter correspondingly be made applicable, as nearly as may reasonably be, in relation to any shares of stock and other securities and property thereafter deliverable on the exercise of the Warrant. The provisions of this Subsection shall similarly apply to successive consolidations, mergers, statutory exchanges, sales or conveyances. The Corporation will not effect any such consolidation, merger or sale unless, prior to the consummation thereof, the successor entity (if other than the Corporation) resulting from such consolidation or the entity purchasing such assets shall assume the obligation to deliver to such Holder such shares of stock, securities or property as, in accordance with the foregoing provisions, such Holder may be entitled to purchase.

(d)

Upon any adjustment of the Warrant Exercise Price, then and in each such case, the Corporation shall give written notice thereof, by first-class mail, postage prepaid, addressed to the Holder as shown on the books of the Corporation, which notice shall state the Warrant Exercise Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of this Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. 

4

(e)

The Corporation shall give notice to the Holder if at any time prior to the expiration or exercise in full of this Warrant, any of the following events shall occur:

(i)

The Corporation shall authorize the payment of any dividend payable in any securities upon shares of Common Stock or authorize the making of any distribution to the holders of shares of Common Stock;

(ii)

The Corporation shall authorize the issuance to all holders of Common Stock of any additional shares of Common Stock or of rights, options or warrants to subscribe for or purchase Common Stock or any of any other subscription rights, options or warrants;

(iii)

A dissolution, liquidation or winding up of the Corporation (other than in connection with a consolidation, merger, or sale or conveyance of the property of the Corporation as an entirety or substantially as an entirety); or

(iv)

A capital reorganization or reclassification of the Common Stock (other than a subdivision or combination of the outstanding Common Stock and other than a change in the par value of the Common Stock) or any consolidation or merger of the Corporation with or into another corporation (other than a consolidation or merger in which the Corporation is the continuing corporation and that does not result in any reclassification or change of Common Stock outstanding) or any sale or conveyance to another corporation of the property of the Corporation as an entirety or substantially an entirety.

Such notice shall be given at least 10 business days prior to the date fixed as a record date or effective date or the date of closing of the Corporation’s stock transfer books for the determination of the stockholders entitled to such dividend, distribution, or subscription rights, or for the determination of the stockholders entitled to vote on such proposed merger, consolidation, sale, conveyance, dissolution, liquidation or winding up.  Such notice shall specify such record date or the date of the closing of the stock transfer books, as the case may be.  

6.

NO VOTING RIGHTS. This Warrant shall not entitle the Holder to any voting rights or other rights as a shareholder of the Corporation. 

7.

NOTICE OF TRANSFER OF WARRANT OR RESALE OF THE WARRANT SHARES. 

(a)

Subject to the sale, assignment, hypothecation, or other transfer restrictions set forth in Section 1 hereof, the Holder, by acceptance hereof, agrees to give written notice to the Corporation before transferring this Warrant or transferring any Warrant Shares of such Holder’s intention to do so, describing briefly the manner of any proposed transfer. Promptly upon receiving such written notice, the Corporation shall present copies thereof to the Corporation’s counsel. If in the opinion of such counsel the proposed transfer may be effected without registration or qualification (under any federal or state securities laws), the Corporation, as promptly as practicable, shall notify the Holder of such opinion, whereupon the Holder shall be entitled to transfer this Warrant or to dispose of Warrant Shares received upon the previous exercise of this Warrant, all in accordance with the terms of the notice delivered by the Holder to the Corporation; provided that an appropriate legend may be endorsed on this Warrant or the 

5

certificates for such Warrant Shares respecting restrictions upon transfer thereof necessary or advisable in the opinion of counsel and satisfactory to the Corporation to prevent further transfers which would be in violation of Section 5 of the 1933 Act and applicable state securities laws; and provided further that the prospective transferee or purchaser shall execute such documents and make such representations, warranties, and agreements as may be required solely to comply with the exemptions relied upon by the Corporation for the transfer or disposition of the Warrant or Warrant Shares. 

(b)

If, in the opinion of the Corporation’s counsel, the proposed transfer or disposition of the Warrant or such Warrant Shares described in the written notice given pursuant to this Section 7 may not be effected without registration or qualification of this Warrant or such Warrant Shares, the Corporation shall promptly give written notice thereof to the Holder, and the Holder will limit its activities in respect to such transfer or disposition as, in the opinion of such counsel, are permitted by law. 

8.

FRACTIONAL SHARES. Fractional shares shall not be issued upon the exercise of this Warrant, but in any case where the Holder would, except for the provisions of this Section, be entitled under the terms hereof to receive a fractional share, the Corporation shall, upon the exercise of this Warrant for the largest number of whole shares then called for, pay a sum in cash equal to such fraction multiplied by the Market Price on the day prior to the date of exercise of this Warrant in lieu of such fractional share. For purposes of this Section, the term “Market Price” with respect to shares of Common Stock of any class or series means the last reported sale price or, if none, the average of the last reported closing bid and asked prices on any national or regional securities exchange or quoted in the Nasdaq Stock Market (“Nasdaq”), or if not listed on a national or regional securities exchange or quoted in Nasdaq, the average of the last reported closing bid and asked prices as reported by the Electronic Bulletin Board of the National Association of Securities Dealers, Inc. from quotations by market makers in such Common Stock on the over-the-counter market, or if no quotations in such Common Stock are available, the fair market value of the shares as determined in good faith by the Board of Directors of the Corporation. 

9.

REDEMPTION. At any time after July 1, 2011, this Warrant may be redeemed by the Corporation, in whole or in part, at a redemption price of $0.05 per Warrant Share (subject to appropriate adjustment as determined in good faith by the Corporation’s Board of Directors in the event of the occurrence of the events described in Sections 5(a)(i), (ii) and (iii)) upon notice of such redemption given by the Corporation to the Holder not less than thirty (30) days prior to the date fixed for redemption in the manner provided in Section10(a) hereof. The Corporation shall be entitled to redeem this Warrant as provided in this Section 9 only if the average closing “bid” Market Price per share of the Common Stock for any twenty (20) consecutive trading days prior to such notice exceeds $3.00 per share (subject to appropriate adjustment as determined in good faith by the Corporation’s Board of Directors in the event of the occurrence of the events described in Sections 5(a)(i), (ii) and (iii)). If notice of redemption shall have been given to the Holders, the exercise rights of this Warrant shall expire at the close of business on such date of redemption, unless extended by the Corporation.  On or prior to the date fixed for redemption,  the Corporation will set aside the funds sufficient to purchase  such portion of this Warrant which is to be redeemed.  Payment of such redemption price will be made by the Corporation upon  presentation and surrender of this Warrant to the Corporation at its principal office. If the 

6

Corporation fails to pay the redemption price within five (5) business days of such presentation and surrender, this Warrant shall become fully exercisable as if it had not been called for redemption.

10.

MISCELLANEOUS.

(a)

NOTICES. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, or (c) two (2) business days after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Corporation at the address as set forth on the signature page hereof, to the Holder at the Holder’s address as appearing on the Corporation’s records, or at such other address as the Corporation or Holder may designate by ten (10) days advance written notice to the other party hereto.

(b)

ATTORNEYS’ FEES. If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and disbursements in addition to any other relief to which such party may be entitled.

(c)

AMENDMENTS AND WAIVERS. This Warrant may be amended or modified only upon the written consent of both Holder and the Corporation. This Warrant and any provision hereof may be waived only by an instrument in writing signed by the party against which enforcement of the same is sought.

(d)

SEVERABILITY. If one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

(e)

GOVERNING LAW. This Warrant shall be governed by and construed and enforced in accordance with the laws of the State of California, without giving effect to its conflicts of laws principles.

(f)

BINDING EFFECT. This Warrant shall be binding upon any entity succeeding the Corporation by merger, consolidation or acquisition of all or substantially all of the Corporation’s assets.  All of the covenants and agreements of the Corporation shall inure to the benefit of the successors and assigns of the Holder hereof. 

7

IN WITNESS WHEREOF, Davi Luxury Brand Group, Inc. has caused this Warrant to be signed by its duly authorized officer and this Warrant to be dated January __, 2011. 

		
	 
	DAVI LUXURY BRAND GROUP, INC.

By:

Name:

Parrish Medley

Title:

Chief Executive Officer

269 S. Beverly Drive, Suite 819

Beverly Hills, California 90212

(310) 271-8390 (fax)

8

(To Be Executed by the Registered Holder in Order to Exercise the Warrant) 

To: Davi Luxury Brand Group, Inc. 

The undersigned hereby irrevocably elects to exercise the attached Warrant to purchase for cash, ____________ of the shares issuable upon the exercise of such Warrant, and requests that certificates for such shares (together with a new Warrant to purchase the number of shares, if any, with respect to which this Warrant is not exercised) shall be issued in the name of: 

		
	NAME:

	 

	SOC. SEC. or

TAX I.D. NO.

	

	ADDRESS:

	

	Date:

, 20_____

	

Signature*

	*  The signature on the Notice of Exercise of Warrant must correspond to the name as written upon the face of the Warrant in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership, trust or other entity, please indicate your position(s) and title(s) with such entity. 

ASSIGNMENT FORM 

(To be Executed by the Registered Holder in Order to Transfer the Warrant) 

To: Davi Luxury Brand Group, Inc. 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers unto _________________________________ the right to purchase the securities of Davi Luxury Brand Group, Inc. to which the within Warrant relates and appoints _______________________________, attorney, to transfer said right on the books of Davi Luxury Brand Group, Inc. with full power of substitution in the premises. 

		
	Date:

, 20_____

	

Signature

	 
	Address:

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]